+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Cardiac Rhythm Management Devices Market Outlook to 2025 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers

  • ID: 5229895
  • Report
  • December 2020
  • Region: North America
  • 128 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Medtronic Plc
  • MORE
North America Cardiac Rhythm Management Devices Market Outlook to 2025 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers

Summary

The publisher’s “North America Cardiac Rhythm Management Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The North America Cardiac Rhythm Management Devices Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Cardiac Rhythm Management Devices Market.
  • Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

North America Cardiac Rhythm Management Devices is segmented as follows -
  • Cardiac Resynchronisation Therapy (CRT)
  • Implantable Cardioverter Defibrillators (ICD)
  • Implantable Loop Recorders (ILR)
  • Pacemakers
Reasons to Buy

The North America Cardiac Rhythm Management Devices Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Medtronic Plc
  • MORE
1 Table of Contents
List of Tables
List of Figures

2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, North America
3.1 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025
3.2 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025
3.3 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
3.4 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
3.5 Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2019

4 Cardiac Rhythm Management Devices Market, Canada
4.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2015-2025
4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2015-2025
4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2015-2025
4.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2015-2025
4.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2025
4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2015-2025
4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2015-2025
4.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2015-2025
4.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($) , 2015-2025
4.4 Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), 2019
4.5 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2019

5 Cardiac Rhythm Management Devices Market, Mexico
5.1 Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2015-2025
5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2015-2025
5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2015-2025
5.1.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2015-2025
5.2 Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2025
5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2015-2025
5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2015-2025
5.2.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2015-2025
5.3 Cardiac Rhythm Management Devices Market, Mexico, Average Price ($) , 2015-2025
5.4 Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), 2019
5.5 Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2019

6 Cardiac Rhythm Management Devices Market, United States
6.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2015-2025
6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2015-2025
6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2015-2025
6.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2015-2025
6.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025
6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2015-2025
6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2015-2025
6.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2015-2025
6.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($) , 2015-2025
6.4 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2019
6.5 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2019

7 Overview of Key Companies in North America Cardiac Rhythm Management Devices Market
7.1 Medtronic Plc
7.1.1 Company Overview
7.2 Abbott Laboratories
7.2.1 Company Overview
7.3 Biotronik AG
7.3.1 Company Overview
7.4 Boston Scientific Corp
7.4.1 Company Overview

8 Cardiac Rhythm Management Devices Market Pipeline Products

9 Recent Developments
9.1 Corporate Communications
9.1.1 Jul 08, 2020: CVRx raises fresh funds to support commercialisation of BAROSTIM NEO
9.1.2 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference
9.1.3 Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs
9.1.4 Dec 10, 2019: New Menarini CELLSEARCH studies to be presented at San Antonio Breast Cancer Symposium
9.1.5 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business
9.1.6 Nov 04, 2019: Ventripoint announces appointment of Justin Leushner as CEO and changes to the board of directors
9.1.7 Nov 01, 2019: Orthofix appoints Jon Serbousek as President and Chief Executive Officer
9.1.8 Sep 24, 2019: Jaguar Health to host investor call to provide updates regarding development of Mytesi for the potential follow-on indication of cancer therapy-related diarrhea
9.1.9 Sep 19, 2019: Ventripoint Diagnostics announces Justin Leushner as new President and Management Restructuring
9.1.10 Sep 16, 2019: Stereotaxis announces CFO transition
9.2 Financial Announcements
9.2.1 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
9.2.2 Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results
9.2.3 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance
9.2.4 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
9.2.5 Dec 23, 2019: iRhythm Technologies files quarterly report on form 10-Q for third quarter 2019 and updates guidance for full year 2019
9.2.6 Dec 09, 2019: ImaginAb initiates phase II clinical trial at Penn Medicine
9.2.7 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results
9.2.8 Nov 05, 2019: iRhythm Technologies announces third quarter 2019 financial results
9.2.9 Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance
9.2.10 Oct 28, 2019: Orthofix reports third quarter 2019 results
9.2.11 Oct 23, 2019: Boston Scientific announces results for third quarter 2019
9.2.12 Sep 25, 2019: Katerzia, the first and only amlodipine oral suspension, 1 mg/mL, is now commercially available for pediatric patients 6 years of age and older
9.2.13 Sep 02, 2019: Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension
9.3 Government and Public Interest
9.3.1 Sep 09, 2019: Theravance Biopharma reports positive results from phase 1 clinical trial of TD-8236, an investigational, lung-selective, inhaled Pan-Janus Kinase (JAK) inhibitor for inflammatory lung diseases
9.3.2 Sep 05, 2019: New caregiver-reported data further validate the use of the aberrant behavior checklist community: FXS specific (ABC-CFXS) subscales to assess core behavioral symptoms of Fragile X Syndrome (FXS)
9.3.3 Aug 29, 2019: Parker Waichman LLP and The Drakulich Firm File TDF Lawsuit
9.4 Other Significant Developments
9.4.1 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
9.4.2 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol
9.4.3 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica
9.5 Product News
9.5.1 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference

10 Appendix

List of Tables
Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025
Table 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020
Table 3: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025
Table 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
Table 5: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2020
Table 6: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2021-2025
Table 7: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2019
Table 8: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 9: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025
Table 10: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2021-2025
Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 13: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2021-2025
Table 14: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 15: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2021-2025
Table 16: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2020
Table 17: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2021-2025
Table 18: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2015-2020
Table 19: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2021-2025
Table 20: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2015-2020
Table 21: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2021-2025
Table 22: Pacemakers Market, Canada, Volume (Units), 2015-2020
Table 23: Pacemakers Market, Canada, Volume (Units), 2021-2025
Table 24: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2015-2020
Table 25: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2021-2025
Table 26: Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2019
Table 27: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2019
Table 28: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020
Table 29: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025
Table 30: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2015-2020
Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2021-2025
Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2015-2020
Table 33: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2021-2025
Table 34: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2015-2020
Table 35: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2021-2025
Table 36: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2020

List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025
Figure 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025
Figure 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
Figure 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
Figure 5: Cardiac Rhythm Management Devices Market, North America, Company Share (%) 2019
Figure 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2025
Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2015-2025
Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2015-2025
Figure 13: Pacemakers Market, Canada, Volume (Units), 2015-2025
Figure 14: Cardiac Rhythm Management Devices Market, Canada, Company Share (%) 2019
Figure 15: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2025
Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2015-2025
Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2015-2025
Figure 18: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2015-2025
Figure 19: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2025
Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2015-2025
Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2015-2025
Figure 22: Pacemakers Market, Mexico, Volume (Units), 2015-2025
Figure 23: Cardiac Rhythm Management Devices Market, Mexico, Company Share (%) 2019
Figure 24: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 27: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 28: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025
Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2025
Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2025
Figure 31: Pacemakers Market, United States, Volume (Units), 2015-2025
Figure 32: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2019
Note: Product cover images may vary from those shown
3 of 3
  • Medtronic Plc
  • Abbott Laboratories
  • Biotronik AG
Note: Product cover images may vary from those shown
Adroll
adroll